Genprex’s ASCO Company Update: Dr. Mark Berger, Chief Medical Officer, Shares Insights on Bell2Bell Podcast

Genprex’s ASCO Company Update: Dr. Mark Berger, Chief Medical Officer, Shares Insights on Bell2Bell Podcast

June 8, 2023Kalyn Dabbs Media Coverage ASCO gene therapy Video

original article: Bell2Bell Podcast featuring Dr. Mark Berger, Chief Medical Officer of Genprex Inc. (NASDAQ: GNPX) [Video Edition] | The Bell2Bell (B2B) Podcast

Designed and Secured by Barsec

Copyright ©2024 all rights reserved.
Home - Privacy Policy - Terms of Use